Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease

Diana M. Toivola, Nam On Ku, Evelyn Z. Resurreccion, David R. Nelson, Teresa L. Wright, M. Bishr Omary

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Keratin 8 and 18 (K8/18) phosphorylation plays a significant and site-specific role in regulating keratin filament organization, association with binding proteins, and modulation of cell cycle progression. Keratin hyperphosphorylation correlates with exposure to a variety of stresses in cultured cells and in mouse models of liver, pancreatic, and gallbladder injury, and it is found in association with mouse and human Mallory bodies. We asked whether K8/18 phosphorylation correlates with human liver disease progression by analyzing liver explants and biopsies of patients with chronic noncirrhotic hepatitis C virus (HCV) or cirrhosis. We also examined the effect of HCV therapy with interleukin-10 on keratin phosphorylation. Using site-specific antiphosphokeratin antibodies we found keratin hyperphosphorylation on most K8/18 sites in all cirrhotic liver explants tested and in most liver biopsies from patients with chronic HCV infection. Immunofluorescence staining of precirrhotic HCV livers showed focal keratin hyperphosphorylation and limited reorganization of keratin filament networks. In cirrhotic livers, keratin hyperphosphorylation occurred preferentially in hepatic nodule cells adjacent to bridging fibrosis and associated with increased stress kinase activation and apoptosis. Histological and serological improvement after interleukin-10 therapy was accompanied by normalization of keratin hyperphosphorylation on some sites in 7 of 10 patients. In conclusion, site-specific keratin phosphorylation in liver disease is a progression marker when increased and a likely regression marker when decreased.

Original languageEnglish
Pages (from-to)459-466
Number of pages8
JournalHepatology
Volume40
Issue number2
DOIs
Publication statusPublished - 2004 Aug 1

Fingerprint

Keratin-8
Keratin-18
Keratins
Liver Diseases
Hepacivirus
Liver
Phosphorylation
Chronic Hepatitis C
Interleukin-10
Fibrosis
Mallory Bodies
Biopsy
Virus Diseases
Gallbladder
Human Body
Fluorescent Antibody Technique
Disease Progression
Hepatocytes
Cultured Cells
Cell Cycle

All Science Journal Classification (ASJC) codes

  • Hepatology

Cite this

Toivola, D. M., Ku, N. O., Resurreccion, E. Z., Nelson, D. R., Wright, T. L., & Omary, M. B. (2004). Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease. Hepatology, 40(2), 459-466. https://doi.org/10.1002/hep.20277
Toivola, Diana M. ; Ku, Nam On ; Resurreccion, Evelyn Z. ; Nelson, David R. ; Wright, Teresa L. ; Omary, M. Bishr. / Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease. In: Hepatology. 2004 ; Vol. 40, No. 2. pp. 459-466.
@article{c367191142bb42249068e8c3e45e652a,
title = "Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease",
abstract = "Keratin 8 and 18 (K8/18) phosphorylation plays a significant and site-specific role in regulating keratin filament organization, association with binding proteins, and modulation of cell cycle progression. Keratin hyperphosphorylation correlates with exposure to a variety of stresses in cultured cells and in mouse models of liver, pancreatic, and gallbladder injury, and it is found in association with mouse and human Mallory bodies. We asked whether K8/18 phosphorylation correlates with human liver disease progression by analyzing liver explants and biopsies of patients with chronic noncirrhotic hepatitis C virus (HCV) or cirrhosis. We also examined the effect of HCV therapy with interleukin-10 on keratin phosphorylation. Using site-specific antiphosphokeratin antibodies we found keratin hyperphosphorylation on most K8/18 sites in all cirrhotic liver explants tested and in most liver biopsies from patients with chronic HCV infection. Immunofluorescence staining of precirrhotic HCV livers showed focal keratin hyperphosphorylation and limited reorganization of keratin filament networks. In cirrhotic livers, keratin hyperphosphorylation occurred preferentially in hepatic nodule cells adjacent to bridging fibrosis and associated with increased stress kinase activation and apoptosis. Histological and serological improvement after interleukin-10 therapy was accompanied by normalization of keratin hyperphosphorylation on some sites in 7 of 10 patients. In conclusion, site-specific keratin phosphorylation in liver disease is a progression marker when increased and a likely regression marker when decreased.",
author = "Toivola, {Diana M.} and Ku, {Nam On} and Resurreccion, {Evelyn Z.} and Nelson, {David R.} and Wright, {Teresa L.} and Omary, {M. Bishr}",
year = "2004",
month = "8",
day = "1",
doi = "10.1002/hep.20277",
language = "English",
volume = "40",
pages = "459--466",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

Toivola, DM, Ku, NO, Resurreccion, EZ, Nelson, DR, Wright, TL & Omary, MB 2004, 'Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease', Hepatology, vol. 40, no. 2, pp. 459-466. https://doi.org/10.1002/hep.20277

Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease. / Toivola, Diana M.; Ku, Nam On; Resurreccion, Evelyn Z.; Nelson, David R.; Wright, Teresa L.; Omary, M. Bishr.

In: Hepatology, Vol. 40, No. 2, 01.08.2004, p. 459-466.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease

AU - Toivola, Diana M.

AU - Ku, Nam On

AU - Resurreccion, Evelyn Z.

AU - Nelson, David R.

AU - Wright, Teresa L.

AU - Omary, M. Bishr

PY - 2004/8/1

Y1 - 2004/8/1

N2 - Keratin 8 and 18 (K8/18) phosphorylation plays a significant and site-specific role in regulating keratin filament organization, association with binding proteins, and modulation of cell cycle progression. Keratin hyperphosphorylation correlates with exposure to a variety of stresses in cultured cells and in mouse models of liver, pancreatic, and gallbladder injury, and it is found in association with mouse and human Mallory bodies. We asked whether K8/18 phosphorylation correlates with human liver disease progression by analyzing liver explants and biopsies of patients with chronic noncirrhotic hepatitis C virus (HCV) or cirrhosis. We also examined the effect of HCV therapy with interleukin-10 on keratin phosphorylation. Using site-specific antiphosphokeratin antibodies we found keratin hyperphosphorylation on most K8/18 sites in all cirrhotic liver explants tested and in most liver biopsies from patients with chronic HCV infection. Immunofluorescence staining of precirrhotic HCV livers showed focal keratin hyperphosphorylation and limited reorganization of keratin filament networks. In cirrhotic livers, keratin hyperphosphorylation occurred preferentially in hepatic nodule cells adjacent to bridging fibrosis and associated with increased stress kinase activation and apoptosis. Histological and serological improvement after interleukin-10 therapy was accompanied by normalization of keratin hyperphosphorylation on some sites in 7 of 10 patients. In conclusion, site-specific keratin phosphorylation in liver disease is a progression marker when increased and a likely regression marker when decreased.

AB - Keratin 8 and 18 (K8/18) phosphorylation plays a significant and site-specific role in regulating keratin filament organization, association with binding proteins, and modulation of cell cycle progression. Keratin hyperphosphorylation correlates with exposure to a variety of stresses in cultured cells and in mouse models of liver, pancreatic, and gallbladder injury, and it is found in association with mouse and human Mallory bodies. We asked whether K8/18 phosphorylation correlates with human liver disease progression by analyzing liver explants and biopsies of patients with chronic noncirrhotic hepatitis C virus (HCV) or cirrhosis. We also examined the effect of HCV therapy with interleukin-10 on keratin phosphorylation. Using site-specific antiphosphokeratin antibodies we found keratin hyperphosphorylation on most K8/18 sites in all cirrhotic liver explants tested and in most liver biopsies from patients with chronic HCV infection. Immunofluorescence staining of precirrhotic HCV livers showed focal keratin hyperphosphorylation and limited reorganization of keratin filament networks. In cirrhotic livers, keratin hyperphosphorylation occurred preferentially in hepatic nodule cells adjacent to bridging fibrosis and associated with increased stress kinase activation and apoptosis. Histological and serological improvement after interleukin-10 therapy was accompanied by normalization of keratin hyperphosphorylation on some sites in 7 of 10 patients. In conclusion, site-specific keratin phosphorylation in liver disease is a progression marker when increased and a likely regression marker when decreased.

UR - http://www.scopus.com/inward/record.url?scp=4043154985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4043154985&partnerID=8YFLogxK

U2 - 10.1002/hep.20277

DO - 10.1002/hep.20277

M3 - Article

C2 - 15368451

AN - SCOPUS:4043154985

VL - 40

SP - 459

EP - 466

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 2

ER -